Maravai LifeSciences Holdings, Inc. MRVI Contract Liabilities
Contract Liabilities at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s contract liabilities?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported contract liabilities of $3.2M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s contract liabilities changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s contract liabilities decreased by 8.6% year-over-year, from $3.5M to $3.2M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s contract liabilities?
- Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s contract liabilities has grown at a -48.0% compound annual growth rate (CAGR), from $79.2M to $3M.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.